Biotechnology in Germany

Biotechnology in Germany


  • Products Id :- OHME7995
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons To Buy

What was the size of the Germany biotechnology market by value in 2016?

What will be the size of the Germany biotechnology market in 2021?

What factors are affecting the strength of competition in the Germany biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Germany's biotechnology market?

Key Highlights

The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The German biotechnology market is expected to generate total revenues of $8.7bn in 2016, representing a compound annual growth rate (CAGR) of 7% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $4.3bn, equivalent to 49.7% of the market's overall value.

There is strong interest in the German biotech industry from foreign players. Japanese Astelles Pharma has entered negotiations to buy Ganymed Pharmaceuticals in order to gain access to the highly regarded cancer antibody technology.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Boehringer Ingelheim GmbH

Merck & Co., Inc.

MorphoSys AG

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

Figure 1: Germany biotechnology industry value: $ million, 2012-16(e)

Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2016(e)

Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2016(e)

Figure 4: Germany biotechnology industry value forecast: $ million, 2016-21

Figure 5: Forces driving competition in the biotechnology industry in Germany, 2016

Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2016

Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2016

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2016

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2016

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2016

Figure 11: Boehringer Ingelheim GmbH: revenues & profitability

Figure 12: Boehringer Ingelheim GmbH: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: MorphoSys AG: revenues & profitability

Figure 16: MorphoSys AG: assets & liabilities

Table 1: Germany biotechnology industry value: $ million, 2012-16(e)

Table 2: Germany biotechnology industry category segmentation: $ million, 2016(e)

Table 3: Germany biotechnology industry geography segmentation: $ billion, 2016(e)

Table 4: Germany biotechnology industry value forecast: $ million, 2016-21

Table 5: Boehringer Ingelheim GmbH: key facts

Table 6: Boehringer Ingelheim GmbH: key financials ($)

Table 7: Boehringer Ingelheim GmbH: key financials (EUR)

Table 8: Boehringer Ingelheim GmbH: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials ($)

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: MorphoSys AG: key facts

Table 13: MorphoSys AG: key financials ($)

Table 14: MorphoSys AG: key financials (EUR)

Table 15: MorphoSys AG: key financial ratios

Table 16: Germany size of population (million), 2012-16

Table 17: Germany gdp (constant 2005 prices, $ billion), 2012-16

Table 18: Germany gdp (current prices, $ billion), 2012-16

Table 19: Germany inflation, 2012-16

Table 20: Germany consumer price index (absolute), 2012-16

Table 21: Germany exchange rate, 2012-16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Boehringer Ingelheim GmbH Merck & Co., Inc. MorphoSys AG

Biotechnology, MarketLine, Germany

select a license

Single User License
USD 350 INR 23608
Site License
USD 700 INR 47215
Corporate User License
USD 1050 INR 70823

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com